Q32 Bio (QTTB) Accumulated Expenses (2017 - 2026)

Q32 Bio's Accumulated Expenses history runs 10 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 28.26% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (down 28.26% YoY), while the FY2025 annual figure was $4.2 million, down 43.41% from the prior year.
• Accumulated Expenses was $3.8 million for Q1 2026 at Q32 Bio, down from $4.2 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $19.8 million in Q1 2024 to a low of $2.4 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $8.1 million across 5 years, with a median of $5.3 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses jumped 687.64% in 2024, then slumped 73.44% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $18.7 million in 2022, then slumped by 47.83% to $9.8 million in 2023, then dropped by 23.39% to $7.5 million in 2024, then sank by 43.41% to $4.2 million in 2025, then retreated by 10.75% to $3.8 million in 2026.
• The last three Accumulated Expenses figures came in at $3.8 million (Q1 2026), $4.2 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.